Cargando…

Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features

Signal transducers and activators of transcription (STATs), their inhibitors and cyclooxygenase-2 (COX-2) participate in transformations of many various types of cancers. The aim of the present study was to evaluate the relationship between STAT5A/B, COX-2, and PIAS3 mRNA expression and tumor stagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastuszak-Lewandoska, Dorota, Domańska, Daria, Czarnecka, Karolina H., Kordiak, Jacek, Migdalska-Sęk, Monika, Nawrot, Ewa, Kiszałkiewicz, Justyna, Antczak, Adam, Górski, Paweł, Brzeziańska, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138089/
https://www.ncbi.nlm.nih.gov/pubmed/25137041
http://dx.doi.org/10.1371/journal.pone.0104265
_version_ 1782331190208888832
author Pastuszak-Lewandoska, Dorota
Domańska, Daria
Czarnecka, Karolina H.
Kordiak, Jacek
Migdalska-Sęk, Monika
Nawrot, Ewa
Kiszałkiewicz, Justyna
Antczak, Adam
Górski, Paweł
Brzeziańska, Ewa
author_facet Pastuszak-Lewandoska, Dorota
Domańska, Daria
Czarnecka, Karolina H.
Kordiak, Jacek
Migdalska-Sęk, Monika
Nawrot, Ewa
Kiszałkiewicz, Justyna
Antczak, Adam
Górski, Paweł
Brzeziańska, Ewa
author_sort Pastuszak-Lewandoska, Dorota
collection PubMed
description Signal transducers and activators of transcription (STATs), their inhibitors and cyclooxygenase-2 (COX-2) participate in transformations of many various types of cancers. The aim of the present study was to evaluate the relationship between STAT5A/B, COX-2, and PIAS3 mRNA expression and tumor staging, metastasis status, and histopathological subtype in 71 patients with confirmed non-small cell lung cancer (NSCLC) diagnosis. Total RNA was isolated from NSCLC tissue samples and the expression of the studied genes was assessed using TaqMan probes in real-time PCR assay. The expression levels of STAT5A, STAT5B, and COX-2 genes were increased in 69%, 79%, and 71% NSCLC samples respectively, while PIAS3 expression was decreased in the majority (69%) of the studied tissues. Statistically significant differences were observed between STAT5 isoforms (P = 0.0008), with higher expression of STAT5B. We found statistically significant positive correlation between STAT5B and COX-2 (rho = 0.045), and significant negative correlation between STAT5B and PIAS3 (rho = −0.049). The negative correlation between STAT5B and PIAS3 (rho = −0.43) was also observed in T2a+T2b tumor group. Additionally, STAT5B and COX-2 expression levels were significantly different between T1a+T1b and T2a+T2b tumors (P = 0.002 and P = 0.041, respectively), with higher expression of both genes in T2 tumor stage. PIAS3 expression was significantly lower in NSCC subtype as compared with SCC subtype (P = 0.017). Also, STAT5A and STAT5B immunoexpression was assessed, and the results indicated significantly higher protein levels in NSCLC patients as compared with controls (P = 0.048 and P = 0.034, respectively). High STAT5B immunoexpression was positively correlated with STAT5B gene expression in tumors (rho = 0.755). STAT5B protein level was also significantly higher in T2a+T2b tumors, reflecting high STAT5B gene expression in this group. There was no statistically significant association between mRNA and protein expression levels of the studied genes and patients' characteristics: age, gender, smoking. The obtained results highlight the importance of the genes STAT5B and COX-2 in lung cancer progression.
format Online
Article
Text
id pubmed-4138089
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41380892014-08-20 Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features Pastuszak-Lewandoska, Dorota Domańska, Daria Czarnecka, Karolina H. Kordiak, Jacek Migdalska-Sęk, Monika Nawrot, Ewa Kiszałkiewicz, Justyna Antczak, Adam Górski, Paweł Brzeziańska, Ewa PLoS One Research Article Signal transducers and activators of transcription (STATs), their inhibitors and cyclooxygenase-2 (COX-2) participate in transformations of many various types of cancers. The aim of the present study was to evaluate the relationship between STAT5A/B, COX-2, and PIAS3 mRNA expression and tumor staging, metastasis status, and histopathological subtype in 71 patients with confirmed non-small cell lung cancer (NSCLC) diagnosis. Total RNA was isolated from NSCLC tissue samples and the expression of the studied genes was assessed using TaqMan probes in real-time PCR assay. The expression levels of STAT5A, STAT5B, and COX-2 genes were increased in 69%, 79%, and 71% NSCLC samples respectively, while PIAS3 expression was decreased in the majority (69%) of the studied tissues. Statistically significant differences were observed between STAT5 isoforms (P = 0.0008), with higher expression of STAT5B. We found statistically significant positive correlation between STAT5B and COX-2 (rho = 0.045), and significant negative correlation between STAT5B and PIAS3 (rho = −0.049). The negative correlation between STAT5B and PIAS3 (rho = −0.43) was also observed in T2a+T2b tumor group. Additionally, STAT5B and COX-2 expression levels were significantly different between T1a+T1b and T2a+T2b tumors (P = 0.002 and P = 0.041, respectively), with higher expression of both genes in T2 tumor stage. PIAS3 expression was significantly lower in NSCC subtype as compared with SCC subtype (P = 0.017). Also, STAT5A and STAT5B immunoexpression was assessed, and the results indicated significantly higher protein levels in NSCLC patients as compared with controls (P = 0.048 and P = 0.034, respectively). High STAT5B immunoexpression was positively correlated with STAT5B gene expression in tumors (rho = 0.755). STAT5B protein level was also significantly higher in T2a+T2b tumors, reflecting high STAT5B gene expression in this group. There was no statistically significant association between mRNA and protein expression levels of the studied genes and patients' characteristics: age, gender, smoking. The obtained results highlight the importance of the genes STAT5B and COX-2 in lung cancer progression. Public Library of Science 2014-08-19 /pmc/articles/PMC4138089/ /pubmed/25137041 http://dx.doi.org/10.1371/journal.pone.0104265 Text en © 2014 Pastuszak-Lewandoska et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Pastuszak-Lewandoska, Dorota
Domańska, Daria
Czarnecka, Karolina H.
Kordiak, Jacek
Migdalska-Sęk, Monika
Nawrot, Ewa
Kiszałkiewicz, Justyna
Antczak, Adam
Górski, Paweł
Brzeziańska, Ewa
Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title_full Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title_fullStr Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title_full_unstemmed Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title_short Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
title_sort expression of stat5, cox-2 and pias3 in correlation with nsclc histhopathological features
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138089/
https://www.ncbi.nlm.nih.gov/pubmed/25137041
http://dx.doi.org/10.1371/journal.pone.0104265
work_keys_str_mv AT pastuszaklewandoskadorota expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT domanskadaria expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT czarneckakarolinah expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT kordiakjacek expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT migdalskasekmonika expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT nawrotewa expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT kiszałkiewiczjustyna expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT antczakadam expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT gorskipaweł expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures
AT brzezianskaewa expressionofstat5cox2andpias3incorrelationwithnsclchisthopathologicalfeatures